Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for NRX Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 44.00 and a low estimate of 19.00. The median estimate represents a 2,360.32% increase from the last price of 1.26.
High | 3,392.1% | 44.00 |
Med | 2,360.3% | 31.00 |
Low | 1,407.9% | 19.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 14, 2024.
Average growth rate | +5.22% |
Average growth rate | +34.43% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼